The evaluation of screening policies for diabetic retinopathy using simulation

Diabetic Medicine

Volumn 19, Issue 9, 2002, Pages 762-770

  Davies, R ^a   Roderick, P ^a   Canning, C ^b   Brailsford, S ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Computer simulation; Diabetes mellitus; Diabetic retinopathy; Health planning; Screening

Indexed keywords

ARTICLE; CAMERA; COMPUTER SIMULATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIABETIC NEPHROPATHY; FOLLOW UP; HEALTH CARE PLANNING; HEALTH CARE POLICY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MYDRIASIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PEER REVIEW; PHOTOGRAPHY; PUBLICATION; RETINOPATHY; SCREENING TEST; SENSITIVITY ANALYSIS; VALIDATION PROCESS;

COMPUTER SIMULATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; ENGLAND; HUMANS; MODELS, THEORETICAL; PATIENT COMPLIANCE; PROGRAM EVALUATION; SENSITIVITY AND SPECIFICITY; VISION SCREENING;

EID: 0036050026     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2002.00773.x     Document Type: Article

References (61)

1. The Wisconsin Epidemiologic study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy
2. Visual impairment in diabetes
3. Survey of diabetic retinopathy screening services in England and Wales
4. Complications of diabetes: Screening for retinopathy, management of foot ulcers
5. Screening for diabetic retinopathy: A relative cost-effectiveness analysis of alternative modalities and strategies
6. Prevention of blindness by screening for diabetic retinopathy: A quantitative assessment
7. Cost-effectiveness of strategies for detecting diabetic retinopathy
8. Impact of diabetic retinopathy screening on a British district population: Case detection and blindness prevention in an evidence-based model
9. Detecting and treating retinopathy in patients with Type 1 diabetes mellitus. Savings associated with improved implementation of current guidelines
10. Cost-effectiveness of the screening and treatment of diabetic retinopathy: What are the costs of underutilization?
11. Simulating health systems: Modelling problems and software solutions
12. Model of complications of NIDDM. Model construction and assumptions
13. Cost effectiveness of screening for sight threatening diabetic eye disease
14. Using simulation modelling for evaluating screening services for diabetic retinopathy
15. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XI. The incidence of macular edema
16. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years
17. Evidence of an increasing prevalence of diagnosed diabetes mellitus in the Poole area from 1983 to 1996
18. Estimating the prevalence of diagnosed diabetes in a health district of Wales: The importance of using primary and secondary care sources of ascertainment with adjustment for death and migration
19. The Dundee prevalence study of insulin-treated diabetes
20. Relationship of glucose intolerance to coronary risk in Afro-Caribbeans compared with Europeans
21. Prevalence of diabetes in a predominantly Asian community: Preliminary findings of the Coventry diabetes study
22. Prevalence and risk of diabetic retinopathy when age at diagnosis is greater than 30 years
23. WESDR IV diabetic macular edema
24. Ophthalmic health care in diabetes mellitus: A cross-sectional study in northern Sweden
25. The aetiology and pathogenesis of IDDM-an epidemiological perspective
26. Type 1 diabetes mellitus
27. Determinants of incident non-insulin-dependent diabetes mellitus among blacks and whites in a national sample. The NHANES I Epidemiologic Follow-up Study
28. Prevalence of diabetic retinopathy in an older community. The Blue Mountains study
29. A four-year follow-up on the incidence of diabetic retinopathy in older onset diabetes mellitus
30. The Wisconsin Epidemiologic Study of Diabetic Retinopathy IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is greater than 30 years
31. The Wisconsin Epidemiologic Study of Diabetic Retinopathy IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years
32. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XV. The long-term incidence of macula edema
33. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes
34. The incidence of visual loss in a diabetic population
35. Photocoagulation treatment of proliferative retinopathy. DRS Report Number 8
36. Relation of ocular and systemic factors to survival in diabetes
37. United Kingdom Prospective Study, 30. Diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors
38. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors
39. UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis
40. Relationship between the severity of retinopathy and progression to photocoagulation in patients with type 2 diabetes mellitus in the UKPDS (UKPDS 52)
41. Does retinal photography improve screening for diabetic retinopathy in the primary care setting?
42. Inter-observer comparisons of ophthalmoscopic assessment of diabetic retinopathy
43. Screening for diabetic retinopathy by general practitioners
44. Screening for diabetic retinopathy. The wide angle retinal camera
45. Effectiveness of screening and monitoring tests for diabetic retinopathy-systematic review
46. Photocoagulation for proliferative diabetic retinopathy: A randomised controlled trial using the xenon-arc
47. Photocoagulation in treatment of diabetic maculopathy
48. The National Diabetic Retinopathy Laser Treatment Audit. III
49. Cost effectiveness of shortening screening interval or extending age range of NHS breast cancer screening programme computer simulation study
50. Cost utility of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus
51. The rising global burden of diabetes and its complications: Estimates and projections to the year 2010
52. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
53. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetics (UKPDS 38)